PharmaBoardroom

Interview: Mikel Arriola – General Director, IMSS, Mexico…

In part one of a two-part interview (read part two here), Mikel Arriola, the recently appointed general director of IMSS (Mexican Social Security…

Digital Disruption in Italy

Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home…

Interview: René Bastl – Managing Director, Merck Czech…

Merck Czech Republic’s MD reveals his plan to double Merck operations within the next five years and talks about the impact of the recent…

Interview: Jiří Drahoš – President, The Czech Academy of…

The president of the Czech Academy of Sciences highlights the responsibility of leading scientists to consider the real life application of their…

Top Pharma Companies in Hungary Ranking

The following chart shows the top pharma companies in Hungary ranked by sales value. Global giant Novartis leads the way with USD 240 million of…

Interview: Rafael Suarez – General Manager, Ferring, Mexico

Rafael Suarez, general manager of Ferring in Mexico, explains how the Swiss biopharmaceutical company is adapting to the recent dynamics affecting…

Interview: Pierre Henry Longeray – President of Biopharma…

As President of Biopharma Activities for Merck in France, Pierre-Henry Longeray reveals how France is the third ranked affiliate after the US and…

Interview: Teresa Corona Vázquez – General Director,…

Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important…

Interview: Axel B. Müller – Managing Director,…

Axel B. Müller, managing director of Intergenerika, the Swiss generics association, reveals the penetration rate of generics in Switzerland; why…

Czech-Slovak Pharma Synergies

The Czech Republic and Slovakia share a common past as Czechoslovakia, which parted in 1993. 23 years later, companies like LEO Pharma, Exeltis,…

Generics Trigger Decline in Italian Prescription Retail Market

The following chart shows the decline of the RX retail market in Italy since 2008, along with the 17% decrease in the average price of RX products per…

Innovation & Growth in Italian Pharma

The following chart shows the leading innovators in Italian pharmaceuticals. Gilead leads the way with 135% growth, all of which comes from the…

Tagged with